Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2010
12/15/2010EP2260869A2 Pharmaceutical product
12/15/2010EP2260863A1 Prophylactic/therapeutic agent for infectious disease
12/15/2010EP2260861A1 Administration of dendritic cells partially matured in vitro for the treatment of tumors
12/15/2010EP2260853A2 Biocompatible polymers for a medical composition
12/15/2010EP2260852A2 Bisphosphonate conjugates and methods of making and using the same
12/15/2010EP2260851A1 Use of pentacyclic triterpene for the preparation of a pharmaceutical compound intended for the treatment of multiple sclerosis
12/15/2010EP2260850A2 A2A receptor antogonists for use in the treatment of movement disorders
12/15/2010EP2260849A1 Compositions and methods of use for tyrosine kinase inhibitors to treat pathogenic infection
12/15/2010EP2260848A1 Aqueous liquid containing gatifloxacin, method for production thereof, and method for prevention of production of precipitates during storage of the aqueous liquid at low temperature or upon freezing/thawing of the aqueous liquid
12/15/2010EP2260847A1 Aqueous liquid containing gatifloxacin
12/15/2010EP2260846A1 Novel methods for the treatment of cancer
12/15/2010EP2260845A2 Use of polyphenols for the treatment of alopecia
12/15/2010EP2260844A1 Combination of an NMDA Receptor Antagonist and a Selective Serotonin Reuptake Inhibitor for the Treatment of Depression and other Mood Disorders
12/15/2010EP2260843A2 Alpha-MSH and derivatives for the induction of tolerance against antigens
12/15/2010EP2260842A2 Uses of perfluorinated carboylic acid derivatives for the manufacture of a medicament for the modulation of body mass
12/15/2010EP2260841A2 Compounds with antiparasitic activity and medicines containing same
12/15/2010EP2260840A2 Compounds with antiparasitic activity and medicines containing same
12/15/2010EP2260839A2 Combination therapy using 1-aminocyclohexane derivatives and acetylcholinesterase inhibitors
12/15/2010EP2260838A1 Drug for preventing vascular restenosis and instrument to be embedded in vessel coated with the drug
12/15/2010EP2260837A1 Pharmaceutical compositions for the coordinated delivery of NSAIDs
12/15/2010EP2260836A2 Rapid release tablet with coated drug-containing core and surrounding taste masking layer
12/15/2010EP2260835A2 Composition for proteasome inhibition
12/15/2010EP2260833A2 Bilayer pharmaceutical tablet comprising telmisartan and a diuretic
12/15/2010EP2260832A2 Optimal polymer mixtures for gastric retentive tablets
12/15/2010EP2260706A2 Improved anti-fungal composition
12/15/2010EP2260102A1 Treating cancer by down-regulating frizzled-4 and/or frizzled-1
12/15/2010EP2260101A1 Microrna (mirna) and downstream targets for diagnostic and therapeutic purposes
12/15/2010EP2260051A1 Glucopyranoside derivatives
12/15/2010EP2260048A1 Porous crystalline hybrid solid for adsorbing and releasing gas of biological interest
12/15/2010EP2260044A2 Thienopyrimidines
12/15/2010EP2260043A1 Substituted sulfonamide derivatives
12/15/2010EP2260042A1 Substituted spirocyclic cyclohexane derivatives
12/15/2010EP2260041A2 Cephalotaxus esters, methods of synthesis, and uses thereof
12/15/2010EP2260039A1 Chalcone linked pyrrolo[2,1-c[[1, 4]benzodiazepine hybrids as potential anticancer agents and process for the preparation thereof
12/15/2010EP2260038A1 Purine derivatives as a3 receptor- selective agonists
12/15/2010EP2260033A1 2-benzoylimidazo[1,2-a]pyridine derivatives, preparation thereof and therapeutic use thereof
12/15/2010EP2260031A1 Compounds that are erk inhibitors
12/15/2010EP2260026A1 Quinazolinone derivatives as tubulin polymerization inhibitors
12/15/2010EP2260025A2 Specific impurities of montelukast
12/15/2010EP2260022A1 Substituted cyclohexyldiamines
12/15/2010EP2260021A1 Substituted 4-aminocyclohexane derivatives
12/15/2010EP2260020A1 Hydroxamate-based inhibitors of deacetylases b
12/15/2010EP2260019A1 Modulation of enzymatic structure, activity, and/or expression level
12/15/2010EP2260017A1 Conformationally constrained carboxylic acid derivatives useful for treating metabolic disorders
12/15/2010EP2259844A1 Compositions and methods for mucositis and oncology therapies
12/15/2010EP2259801A1 Stable pharmaceutical compositions of carvedilol
12/15/2010EP2259800A1 Use of pyrimidine derivatives for the treatment of egfr dependent diseases or diseases that have acquired resistance to agents that target egfr family members
12/15/2010EP2259799A1 Combination of immunomodulator and anti-pathogenic agent
12/15/2010EP2259798A1 Compositions and methods for drug delivery
12/15/2010EP2259797A2 Methods for treating or preventing colorectal cancer
12/15/2010EP2259790A1 Abca-1 elevating compounds and the use thereof
12/15/2010EP2259789A2 Pharmaceutical kit consisting of an oil-in-water emulsion and a solid composition
12/15/2010EP2259788A2 Treatment of bladder diseases with a tlr7 activator
12/15/2010EP2259787A2 Ikki inhibitor therapies and screening methods, and related ikki diagnostics
12/15/2010EP2259786A2 Method for inhibiting the build-up of arterial plaque by administering fullerenes
12/15/2010EP2259785A2 Fullerene therapies for inflammation
12/15/2010EP2259784A1 Composition and method for irrigation of a prepared dental root canal
12/15/2010EP2259783A2 3-(2-dimethylaminomethyl-cyclohexyl)-phenol against polyneuropathic pain
12/15/2010EP2259782A1 Pharmaceutical formulations of resveratrol and methods of use thereof for treating cell disorders
12/15/2010EP2259781A1 Process for preparing a pharmaceutical composition with anti-inflammatory and analgesic activity for administration via a patch for external use, and composition thus obtained
12/15/2010EP2259780A2 Pharmaceutical composition comprising naltrexone
12/15/2010EP2259777A2 Pharmaceutical composition for poorly soluble drugs
12/15/2010EP2259773A1 Macrolide compositions having improved taste and stability
12/15/2010EP2259772A2 Ccr5 antagonists as prophylactics for preventing hiv infection and methods of inhibiting transmission of same
12/15/2010EP2259771A1 Stimulation of ocular retrobulbar flow using ocular irritants
12/15/2010EP2259681A1 Dual pharmacophores-pde4-muscarinic antagonistics
12/15/2010EP2259680A1 Soluble epoxide hydrolase inhibitors, compositions containing such compounds and methods of treatment
12/15/2010EP2259679A1 Methods for treatment of kallikrein-related disorders
12/15/2010EP2259678A1 Protein kinase modulators
12/15/2010EP2259677A2 Systemic purine administration:modulating axonal outgrowth of central nervous system neurons
12/15/2010EP2259676A1 Pharmaceutical compositions of a combination of metformin and a dipeptidyl peptidase-iv inhibitor
12/15/2010EP2114878B1 5-(heterocyclyl)alkyl-n-(arylsulfonyl)indole compounds and their use as 5-ht6 ligands
12/15/2010EP2089032B1 A pharmaceutical composition having antipsychotic, antidepressant or antiepileptic activity with reduced side effect
12/15/2010EP2068863B1 Ligustilide for the treatment of disorders of the central nervous system
12/15/2010EP2048145B1 Protein kinase c activity enhancer containing alkyl ether derivative or salt thereof
12/15/2010EP2046332B1 Concentrated methotrexate solutions
12/15/2010EP2046309B1 Use of vitamin d3 agonist mc903 in a mammalian model for atopic diseases
12/15/2010EP2000465B1 Triazolone derivative
12/15/2010EP1984366B1 3, 9-diazabicyclo ý3.3. 1¨nonane derivatives and their use as monoamine?neurotransmitter re-uptake inhibitors
12/15/2010EP1926720B1 CRYSTALLINE FORMS OF 1-CHLORO-4-(ß-D-GLUCOPYRANOS-1-YL)-2-(4-ETHYNYL-BENZYL)-BENZENE, METHODS FOR ITS PREPARATION AND THE USE THEREOF FOR PREPARING MEDICAMENTS
12/15/2010EP1914232B1 N-dihydroxyalkyl-substituted 2-oxoimidazole derivatives
12/15/2010EP1905443B1 Liquid comprising trehalose for use in preventing tissue adhesion
12/15/2010EP1875910B1 Application of levo-ornidazole in preparation of anti-anaerobic bacteria infection medicine
12/15/2010EP1866292B1 Tricyclic 1,2,4-triazine oxides and compositions therefrom for therapeutic use in cancer treatments
12/15/2010EP1848723B1 New isothiazoloquinolones and related compounds as anti-infective agents
12/15/2010EP1839677B1 Adjuvant of fluorocarbon emulsions for hifu therapy and the use thereof
12/15/2010EP1838172B1 Novel nutraceutical compositions
12/15/2010EP1830801B1 Drop preparations comprising dimetindene
12/15/2010EP1828222B1 Process for the preparation of drospirenone
12/15/2010EP1827495B1 Painkilling association comprising a dihydroimidazopyrazine derivative
12/15/2010EP1827379B1 Formulations containing alkylphosphocholines using novel negative charge carriers
12/15/2010EP1814558B1 Methods and compositions for reducing neurodegeneration in amyotrophic lateral sclerosis
12/15/2010EP1807084B1 Use of pyrrolopyrazine derivatives for the production of medicaments for the treatment of mucoviscidosis
12/15/2010EP1802295B1 Oral pharmaceutical composition for targeted transport of a platinum complex into the colorectal region, method for producing and use as medicament thereof
12/15/2010EP1781625B1 Substituted amide beta secretase inhibitors
12/15/2010EP1771424B1 Novel 2,4-diaminothiazol-5-one derivatives
12/15/2010EP1761253B1 Hyaluronic acid in the enhancement of lens regeneration
12/15/2010EP1758998B1 Oligoribonucleotides and methods of use thereof for treatment of fibrotic conditions and other diseases
12/15/2010EP1758591B2 Invert emulsion composition containing calcitriol and clobetasol 17-propionate, and uses thereof in cosmetics and dermatology
12/15/2010EP1756104B1 Tetrahydronaphthyridine derivatives useful as histamine h3 receptor ligands
1 ... 1957 1958 1959 1960 1961 1962 1963 1964 1965 1966 1967 1968 1969 1970 1971 1972 1973 1974 1975 1976 1977 ... 7860